Takeda Goes Virtual, Splitting Non-oncology Development Between Covance And Quintiles
This article was originally published in PharmAsia News
Executive Summary
TOKYO - Takeda Pharmaceuticals has teamed with contract research organizations Covance and Quintiles to move toward a "fully virtual outsourcing model," the company announced Feb. 15